Vortioxetine (Lu AA21004) HBr

Catalog No.S8021

Vortioxetine (Lu AA21004) is a multimodal serotonergic agent, inhibits 5-HT1A, 5-HT1B, 5-HT3A, 5-HT7 receptor and SERT with IC50 of 15 nM, 33 nM, 3.7 nM, 19 nM and 1.6 nM, respectively. Phase 3.

Price Stock Quantity  
In DMSO USD 410 In stock
USD 147 In stock
USD 997 In stock
Bulk Inquiry

Massive Discount Available

Free Overnight Delivery on all orders over $ 500.

Vortioxetine (Lu AA21004) HBr Chemical Structure

Vortioxetine (Lu AA21004) HBr Chemical Structure
Molecular Weight: 379.36

Validation & Quality Control

Quality Control & MSDS

Product Information

  • Inhibition Profile
  • Compare 5-HT Receptor Modulators
    Compare 5-HT Receptor Modulators
  • Research Area

Product Description

Biological Activity

Description Vortioxetine (Lu AA21004) is a multimodal serotonergic agent, inhibits 5-HT1A, 5-HT1B, 5-HT3A, 5-HT7 receptor and SERT with IC50 of 15 nM, 33 nM, 3.7 nM, 19 nM and 1.6 nM, respectively. Phase 3.
Targets 5-HT1A 5-HT1B 5-HT3A 5-HT7 SERT
IC50 15 nM 33 nM 3.7 nM 19 nM 1.6 nM [1]
In vitro Lu-AA21004 inhibits recombinant human CYP1A2, CYP2C9, CYP2D6 and CYP3A4 with IC50 of 40 μM, 39 μM, 9.8 μM and 10 μM, respectively. [1] Lu AA21004 is a partial h5-HT1B receptor agonist with EC50 of 460 nM and intrinsic activity of 22% using a whole-cell cAMP-based assay. Lu AA21004 binds to the r5-HT7 receptor with a Ki value of 200 nM and is a functional antagonist at the r5-HT7 receptor with an IC50 of 2 μM in an in vitro whole-cell cAMP assay. [2]
In vivo For Lu-AA21004 the hepatic clearances and oral bioavailabilities in rats are found to be 7.1 (L/h)/kg and 16%. Lu-AA21004 (2.5 mg/kg, 5 mg/kg, or 10 mg/kg sc) increases the extracellular levels of 5-HT in the ventral hippocampus in conscious rats. Lu-AA21004 (5 mg/kg, or 10 mg/kg sc) also results in significantly higher basal levels of 5-HT in the medial prefrontal cortex (mPFC) after 3 days of treatment. Lu-AA21004 occupies SERT by 43% and 57% after 3 days of treatment with 5 mg/kg or 10 mg/kg in the rat medial prefrontal cortex. [1] Lu AA21004 dose-dependent occupies 5-HT1B receptor and the SERT with ED50 of 3.2 mg/kg and 0.4 mg/kg in rats one hour after subcutaneous administration. Lu AA21004 affects the Bezold-Jarisch reflex in the rat dose dependently, inhibiting transient bradycardia with ED50 of 0.11 mg/kg. Lu AA21004 (2.5-10.0 mg/kg s.c.) increases extracellular levels of 5-HT, DA, and NA in the medial prefrontal cortex and in the ventral hippocampus in rats. Lu AA21004 (5 mg/kg s.c.) increases in the extracellular levels of 5-HT (200%) in the ventral hippocampus of rats with 41% occupancy at the SERT. Lu AA21004 (7.8 mg/kg s.c.) significantly decreases the immobility time in the FSL rats but not in the FRL rats. Lu AA21004 (8.0 mg/kg p.o.) produces an increase in social interaction as well as a small, but significant, increase in locomotor activity in rats. Lu AA21004 (7.9 mg/kg s.c.) shows a dose-dependent anxiolytic-like effect in the conditioned fear assay in rats. [2] Vortioxetine (10 mg/kg) significantly increases freezing 60 min before acquisition in male Sprague-Dawley rats, suggesting enhanced contextual memory formation during acquisition and/or consolidation. Vortioxetine (5 mg/kg) also causes increased freezing rates during retention, an effect that reached statistical significance by post hoc tests. Vortioxetine (2.5 mg/kg or 5 mg/kg) prior to acquisition shows average exploration times of 29s and 33s for the novel object, respectively. Vortioxetine (10 mg/kg) significantly reduces nociception in rats, assessed as increased paw withdrawal latency. Vortioxetine at 5 and 10 mg/kg increases the levels of ACh to 224% and 204% of baseline 20 min after injection. [3]
Features A multimodal antidepressant.

Protocol(Only for Reference)

Kinase Assay: [1]

h5-HT3A Binding Affinity Assay [3H]Granisetron (1 nM) binding to h5-HT3A receptors is evaluated in membranes from a HEK-293 cell line stably expressing the hHT3A receptor. Nonspecific binding is measured in the presence of 10 μM bemesetron. After incubation, the membrane preparations are rapidly filtered under a vacuum using glass-fiber filters. Lu-AA21004 are tested at least three times over a 6 log concentration range. IC50 values are determined by nonlinear regression analysis using Hill equation curve fitting, and Ki values are calculated based on the Cheng−Prusoff equation.

Animal Study: [1]

Animal Models Rats
Dosages 10 mg/kg
Administration Subcutaneous
Solubility 15% Captisol, pH 9 10 mg/mL
1

References

Clinical Trial Information( data from http://clinicaltrials.gov)

NCT Number Recruitment Conditions Sponsor
/Collaborators
Start Date Phases
NCT01488071 Completed Major Depressive Disorder H. Lundbeck A/S 2012-01 Phase 3
NCT01491035 Recruiting Depressive Disorder|Anxiety Disorder H. Lundbeck A/S 2012-04 Phase 2
NCT01571453 Recruiting Major Depressive Disorder H. Lundbeck A/S 2012-05 Phase 3
NCT01607125 Recruiting Depression H. Lundbeck A/S 2012-07 Phase 1
NCT01676571 Completed Healthy H. Lundbeck A/S 2012-10 Phase 1

Chemical Information

Download Vortioxetine (Lu AA21004) HBr SDF
Molecular Weight (MW) 379.36
Formula

C18H22N2S.HBr

CAS No. 960203-27-4
Storage 3 years -20℃Powder
6 months-80℃in DMSO
Syonnyms N/A
Solubility (25°C) * In vitro DMSO 76 mg/mL (200 mM)
Water <1 mg/mL (<1 mM)
Ethanol 17 mg/mL (44 mM)
In vivo 15% Captisol, pH 9 10 mg/mL
* <1 mg/ml means slightly soluble or insoluble.
* Please note that Selleck tests the solubility of all compounds in-house, and the actual solubility may differ slightly from published values. This is normal and is due to slight batch-to-batch variations.
Chemical Name Piperazine, 1-[2-[(2,4-dimethylphenyl)thio]phenyl]-, hydrobromide (1:1)

Preparing Stock Solutions

Stock Solution (1ml DMSO) 1mM 10mM 20mM 30mM
Mass(mg) 0.37936 3.7936 7.5872 11.3808

Research Area

Tech Support & FAQs

Answers to questions you may have can be found in the inhibitor handling instructions. Topics include how to prepare stock solutions, how to store inhibitors, and issues that need special attention for cell-based assays and animal experiments.

Tel: +1-832-582-8158 Ext:3

If you have any other enquiries, please leave a message.

* Indicates a Required Field

Related 5-HT Receptor Modulators

  • Vortioxetine (Lu AA21004) HBr

    Vortioxetine (Lu AA21004) is a multimodal serotonergic agent, inhibits 5-HT1A, 5-HT1B, 5-HT3A, 5-HT7 receptor and SERT with IC50 of 15 nM, 33 nM, 3.7 nM, 19 nM and 1.6 nM, respectively. Phase 3.

    Features:A multimodal antidepressant.

  • PRX-08066 Maleic acid

    PRX-08066 is a selective 5-HT2B receptor antagonist with IC50 of 3.4 nM, prevents the severity of pulmonary arterial hypertension in the MCT rat model. Phase 2.

    Features:A selective 5-HT2BR antagonist and high selectivity over the closely related 5-HT2A and 5-HT2C receptors and other receptor targets.

  • (+)-Bicuculline

    (+)-Bicuculline is a competitive antagonist of GABAA receptors with IC50 of 2 μM, also blocks Ca(2+)-activated potassium channels.

  • Olanzapine

    Olanzapine is a high affinity for 5-HT2 serotonin and D2 dopamine receptor antagonist.

  • Clozapine

    Clozapine is a potent 5-HT1C receptor antagonist with an IC50 of 110 nM for 5-HT-stimulated phosphoinositide hydrolysis.

  • Fluoxetine HCl

    Fluoxetine HCl is an antidepressant of the selective serotonin reuptake inhibitor (SSRI)class.

  • Ketanserin

    Ketanserin is specific 5-HT2A serotonin receptor antagonist with a Ki of 2.5 nM for rat and human 5-HT2A.

  • Agomelatine

    Agomelatine is classified as a norepinephrine-dopamine disinhibitor (NDDI) due to its antagonism of the 5-HT2C receptor.

  • Sumatriptan Succinate

    Sumatriptan Succinate is a triptan sulfa drug containing a sulfonamide group for the treatment of migraine headaches.

  • RS-127445

    RS-127445 is a selective 5-HT2B receptor antagonist with pKi of 9.5 and pIC50 of 10.4, exhibits >1000-fold selectivity against other 5-HT receptors.

Recently Viewed Items

Tags: buy Vortioxetine (Lu AA21004) HBr | Vortioxetine (Lu AA21004) HBr supplier | purchase Vortioxetine (Lu AA21004) HBr | Vortioxetine (Lu AA21004) HBr cost | Vortioxetine (Lu AA21004) HBr manufacturer | order Vortioxetine (Lu AA21004) HBr | Vortioxetine (Lu AA21004) HBr distributor
Contact Us